查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402077

全球医用吸入一氧化氮市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、成长、趋势和预测

Global Medical Inhaled Nitric Oxide Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

全球医用吸入一氧化氮市场需求预计将从 2022 年的 985.56 百万美元达到 2030 年近 1892.87 百万美元的市场规模，2023-2030 年研究期间CAGR为 8.5%。

医用吸入一氧化氮 (iNO) 是一种气体药物，用于治疗各种呼吸系统疾病，特别是那些涉及肺动脉高压或低氧血症（低血氧水平）的疾病。它透过吸入作为一种治疗干预措施来改善氧合和控制肺血管疾病。

市场动态

急性呼吸窘迫症候群 (ARDS) 和肺动脉高压等呼吸系统疾病的发生率不断增加，推动了对吸入一氧化氮 (iNO) 等治疗方法的需求，以控制这些疾病并增强氧合。在新生儿护理中，iNO 在治疗新生儿持续性肺动脉高压方面发挥关键作用，这与对早产儿健康的高度关注和新生儿护理实践的进步相一致。医疗保健技术的进步、改进的输送系统和监测工具提高了 iNO 疗法的安全性和有效性，扩大了其在临床环境中的采用。 iNO 在治疗肺血管疾病和改善氧合方面的临床有效性已得到证实，这促进了其在医疗保健专业人员中的接受度。此外，正在进行的研究探索 iNO 在治疗其他呼吸系统疾病方面的潜力，加上监管支持和医疗保健支出的增加，共同推动了市场扩张。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球医用吸入一氧化氮市场的各个细分市场进行了包容性评估。医用吸入一氧化氮产业的成长和趋势为本研究提供了整体方法。

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲医用吸入一氧化氮市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。医用吸入一氧化氮市场的主要参与者包括 Bellerophon Therapeutics、Praxair Technology Inc.（Linde plc）、Mallinckrodt Pharmaceuticals、GE Healthcare、Mitsubishi Tanabe Pharma Corporation、Vero Biotech LLC、Messer Group、Air Liquide、Nu-Med Plus、Beyond航空公司等。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：医用吸入一氧化氮 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 市场吸引力分析：按产品类型
    • 按给药途径进行的市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球医用吸入一氧化氮市场分析：依产品类型

  • 概述：按产品类型
  • 历史和预测数据
  • 分析：依产品类型
  • 吸入一氧化氮输送系统
  • 一氧化氮感测器和监视器

第 6 章：全球医用吸入一氧化氮市场分析：依给药途径

  • 依给药途径概述
  • 历史和预测数据
  • 依给药途径分析
  • 吸入一氧化氮气体
  • 吸入一氧化氮与氧气混合物

第 7 章：全球医用吸入一氧化氮市场分析：按应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 心血管疾病
  • 呼吸系统疾病

第 8 章：全球医用吸入一氧化氮市场分析：按最终用户分类

  • 最终用户概述
  • 历史和预测数据
  • 最终用户分析
  • 医院
  • 诊所

第 9 章：全球医用吸入一氧化氮市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第10章：医用吸入一氧化氮公司的竞争格局

  • 医用吸入一氧化氮市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Bellerophon Therapeutics
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Praxair Technology Inc. (Linde plc)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Mallinckrodt Pharmaceuticals
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GE Healthcare
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Mitsubishi Tanabe Pharma Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Vero Biotech LLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Messer Group
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Air Liquide
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Nu-Med Plus
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Beyond Air Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • 其他的
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR112112999

The global demand for Medical Inhaled Nitric Oxide Market is presumed to reach the market size of nearly USD 1892.87 MN by 2030 from USD 985.56 MN in 2022 with a CAGR of 8.5% under the study period 2023 - 2030.

Medical inhaled nitric oxide (iNO) is a gas medication used in the treatment of various respiratory conditions, particularly those involving pulmonary hypertension or hypoxemia (low blood oxygen levels). It is delivered through inhalation as a therapeutic intervention to improve oxygenation and manage pulmonary vascular disorders.

MARKET DYNAMICS

The increasing incidence of respiratory disorders, including acute respiratory distress syndrome (ARDS) and pulmonary hypertension, propels the demand for therapies like inhaled nitric oxide (iNO) to manage these conditions and enhance oxygenation. Within neonatal care, iNO plays a critical role in treating persistent pulmonary hypertension in neonates, aligning with the heightened focus on preterm infant health and advancements in neonatal care practices. Advancements in healthcare technology, improved delivery systems, and monitoring tools enhance the safety and efficacy of iNO therapy, augmenting its adoption in clinical settings. The proven clinical effectiveness of iNO in managing pulmonary vascular disorders and improving oxygenation fosters its acceptance among healthcare professionals. Moreover, ongoing research exploring iNO's potential in treating additional respiratory conditions, alongside regulatory support and increased healthcare spending, collectively drive market expansion.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of medical inhaled nitric oxide. The growth and trends of medical inhaled nitric oxide industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the medical inhaled nitric oxide market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Inhaled Nitric Oxide Delivery Systems
  • Nitric Oxide Sensors And Monitors

By Route Of Administration

  • Inhaled Nitric Oxide Gas
  • Inhaled Nitric Oxide With Oxygen Mixtures

By Application

  • Cardiovascular Disorders
  • Respiratory Disorders

By End User

  • Hospitals
  • Clinics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Medical Inhaled Nitric Oxide market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Medical Inhaled Nitric Oxide market include Bellerophon Therapeutics, Praxair Technology Inc. (Linde plc), Mallinckrodt Pharmaceuticals, GE Healthcare, Mitsubishi Tanabe Pharma Corporation, Vero Biotech LLC, Messer Group, Air Liquide, Nu-Med Plus, Beyond Air Inc., and others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . MEDICAL INHALED NITRIC OXIDE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Route of Administration
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1 Overview by Product Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product Type
  • 5.4 Inhaled Nitric Oxide Delivery Systems Historic and Forecast Sales by Regions
  • 5.5 Nitric Oxide Sensors and Monitors Historic and Forecast Sales by Regions

6 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1 Overview by Route of Administration
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Route of Administration
  • 6.4 Inhaled Nitric Oxide Gas Historic and Forecast Sales by Regions
  • 6.5 Inhaled Nitric Oxide with Oxygen Mixtures Historic and Forecast Sales by Regions

7 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Cardiovascular Disorders Historic and Forecast Sales by Regions
  • 7.5 Respiratory Disorders Historic and Forecast Sales by Regions

8 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY END USER

  • 8.1 Overview by End User
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End User
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Clinics Historic and Forecast Sales by Regions

9 . GLOBAL MEDICAL INHALED NITRIC OXIDE MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE MEDICAL INHALED NITRIC OXIDE COMPANIES

  • 10.1. Medical Inhaled Nitric Oxide Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF MEDICAL INHALED NITRIC OXIDE INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Bellerophon Therapeutics
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Praxair Technology Inc. (Linde plc)
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Mallinckrodt Pharmaceuticals
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. GE Healthcare
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Mitsubishi Tanabe Pharma Corporation
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Vero Biotech LLC
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Messer Group
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Air Liquide
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Nu-Med Plus
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Beyond Air Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Others
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Type (USD MN)
  • Inhaled Nitric Oxide Delivery Systems Market Sales by Geography (USD MN)
  • Nitric Oxide Sensors and Monitors Market Sales by Geography (USD MN)
  • Analysis Market by Route of Administration (USD MN)
  • Inhaled Nitric Oxide Gas Market Sales by Geography (USD MN)
  • Inhaled Nitric Oxide with Oxygen Mixtures Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Cardiovascular Disorders Market Sales by Geography (USD MN)
  • Respiratory Disorders Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Global Medical Inhaled Nitric Oxide Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Medical Inhaled Nitric Oxide Report
  • Market Research Process
  • Market Research Methodology
  • Global Medical Inhaled Nitric Oxide Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Route of Administration
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Inhaled Nitric Oxide Delivery Systems Market Sales by Geography (USD MN)
  • Nitric Oxide Sensors and Monitors Market Sales by Geography (USD MN)
  • Global Market Analysis by Route of Administration (USD MN)
  • Inhaled Nitric Oxide Gas Market Sales by Geography (USD MN)
  • Inhaled Nitric Oxide with Oxygen Mixtures Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Cardiovascular Disorders Market Sales by Geography (USD MN)
  • Respiratory Disorders Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.